PMID: 9419453Jan 7, 1998Paper

Dendritic cell-based immunotherapy of prostate cancer

Critical Reviews in Immunology
M L SalgallerG Murphy

Abstract

The immunotherapy of cancer, based on eliciting or enhancing the body's own capacity to mount an effective antitumor response, has produced encouraging early results in the areas of melanoma and renal-cell carcinoma. Such treatments utilizing dendritic cells (DC), immune cells that are excellent antigen presenters, are especially promising. We performed a phase I clinical trial assessing the administration of autologous DC pulsed with HLA-A0201-specific prostate-specific membrane antigen (PSMA) for the treatment of 51 men with hormone-refractory prostate cancer. Participants were divided into five groups receiving four or five infusions of peptides alone (PSM-P1 or PSM-P2; group 1 and 2, respectively), autologous DC (group 3), or DC pulsed with PSM-P1 or P2 (group 4 and 5, respectively). No significant toxicity was observed. Immune reactivity against PSM-P2 was detected in HLA-A2+ patients infused with DC pulsed with PSM-P1 or -P2 (group 4 and 5). An average decrease in PSA was observed only in group 5. Seven partial responders were identified based on NPCP criteria + PSA. The excellent tolerance of this treatment approach, as well as the enhanced cellular responses, decreased PSA levels, and partial clinical responses in some ...Continue Reading

Citations

Jul 5, 2003·International Journal of Hematology·David H Chang, Madhav V Dhodapkar
Jun 27, 2002·Current Urology Reports·Fernando A Ferrer, Ronald Rodriguez
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Duane A Mitchell, John H Sampson
Sep 4, 1999·Urology·R Rodriguez, J W Simons
Sep 21, 2000·Immunology Letters·M Nouri-ShiraziK Palucka
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
Sep 30, 2005·Journal of Biomedicine & Biotechnology·Paulus TsuiPatrick Guinan
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K J O'ByrneA L Harris
Dec 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·M MercaderE D Kwon
Nov 4, 2000·Expert Opinion on Investigational Drugs·L A Jones, M L Salgaller
Nov 4, 2000·Expert Opinion on Investigational Drugs·M L Salgaller
Jan 27, 2009·Advanced Drug Delivery Reviews·David M Lubaroff, Dev Karan
Jun 30, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A J BremersG Parmiani
Mar 4, 2000·Biochimica Et Biophysica Acta·T H Scott-TaylorA G Dalgleish
Dec 1, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·K A BerlynD L Mann
Mar 16, 2018·Chemistry : a European Journal·Bishnu P JoshiMichelle E Farkas
Jul 3, 2002·Nature Reviews. Cancer·Stefan Stevanovic
Dec 26, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tomohide TatsumiNorio Hayashi
Mar 24, 1998·Nature·W Martin, M Müller
Oct 29, 2004·Nature·Ping XuGregory A Buck
Oct 16, 2001·Drugs & Aging·S Matzku, M Zöller
Jan 1, 2007·Social Work in Public Health·Catherine G GreenoMartha Shumway
Oct 16, 2014·Administration and Policy in Mental Health·Dave F SmitsDirk J M Smits
Sep 12, 2014·Administration and Policy in Mental Health·Kim de Jong
Jun 10, 2000·Immunology and Cell Biology·I D Davis
May 10, 2002·Journal of Immunotherapy·Hiromune ShimamuraJoseph Baar
Jan 22, 2003·Immunology and Cell Biology·Ian F C McKenzieBruce E Loveland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.